- Home
- SUNS vs LXRX Comparison
SUNS vs LXRX Comparison
Compare SUNS & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUNS
- LXRX
- Stock Information
- Founded
- SUNS 2023
- LXRX 1995
- Country
- SUNS United States
- LXRX United States
- Employees
- SUNS N/A
- LXRX N/A
- Industry
- SUNS Real Estate Investment Trusts
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- SUNS Real Estate
- LXRX Health Care
- Exchange
- SUNS Nasdaq
- LXRX Nasdaq
- Market Cap
- SUNS 148.2M
- LXRX 124.4M
- IPO Year
- SUNS N/A
- LXRX 2000
- Fundamental
- Price
- SUNS $9.06
- LXRX $0.51
- Analyst Decision
- SUNS Strong Buy
- LXRX Buy
- Analyst Count
- SUNS 3
- LXRX 4
- Target Price
- SUNS $13.42
- LXRX $3.67
- AVG Volume (30 Days)
- SUNS 165.4K
- LXRX 32.2M
- Earning Date
- SUNS 05-07-2025
- LXRX 05-01-2025
- Dividend Yield
- SUNS 10.23%
- LXRX N/A
- EPS Growth
- SUNS N/A
- LXRX N/A
- EPS
- SUNS 1.00
- LXRX N/A
- Revenue
- SUNS $10,588,270.00
- LXRX $31,081,000.00
- Revenue This Year
- SUNS $141.80
- LXRX N/A
- Revenue Next Year
- SUNS $53.98
- LXRX $63.36
- P/E Ratio
- SUNS $9.06
- LXRX N/A
- Revenue Growth
- SUNS 1342.10
- LXRX 2481.48
- 52 Week Low
- SUNS $7.80
- LXRX $0.28
- 52 Week High
- SUNS $15.74
- LXRX $2.45
- Technical
- Relative Strength Index (RSI)
- SUNS N/A
- LXRX 53.30
- Support Level
- SUNS N/A
- LXRX $0.48
- Resistance Level
- SUNS N/A
- LXRX $0.60
- Average True Range (ATR)
- SUNS 0.00
- LXRX 0.09
- MACD
- SUNS 0.00
- LXRX 0.01
- Stochastic Oscillator
- SUNS 0.00
- LXRX 42.86
About SUNS Sunrise Realty Trust Inc. Common Stock
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.